IMU-381
/ Immunic
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 11, 2026
Anticipated Clinical Milestones:…IMU-381
(PRNewswire)
- "The IMU-381 program, selected to leverage the Nurr1 platform for neurologic and autoimmune diseases, continues to be in preclinical testing with lead candidate identification ongoing."
Preclinical • Immunology
1 to 1
Of
1
Go to page
1